Deleted In Colorectal Cancer Is A Putative Conditional Tumor-Suppressor Gene Inactivated By Promoter Hypermethylation In Head And Neck Squamous Cell Carcinoma
andre lopes carvalho,alice chuang,weiwen jiang,juna lee,shahnaz begum,luana poeta,ming zhao,carmen jeronimo,rui henrique,chetan s nayak,hannah lui park,mariana brait,chunyan liu,shaoyu zhou,wayne m koch,vito michele fazio,edward a ratovitski,barry trink,william h westra,Sidransky David,Moon Chul-so,Califano Joseph A
DOI: https://doi.org/10.1158/0008-5472.CAN-06-1073
IF: 11.2
2006-01-01
Cancer Research
Abstract:Deleted in colorectal cancer (DCC) is a candidate tumor-suppressor gene located at chromosome 18q21. However, DCC gene was found to have few somatic mutations and the heterozygous mice (DCC+/-) showed a similar frequency of tumor formation compared with the wild-type mice (DCC+/+). Recently, DCC came back to the spotlight as a better understating of its function and relationship with its ligand (netrin-1) had shown that DCC may act as a conditional tumor-suppressor gene. We evaluated hypermethylation as a mechanism for DCC inactivation in head and neck squamous cell carcinoma (HNSCC). DCC promoter region hypermethylation was found in 75% of primary HNSCC. There was a significant correlation between DCC promoter region hypermethylation and DCC expression (assessed by immunohistochemistry; P = 0.021). DCC nonexpressing HNSCC cell lines JHU-O12 and JHU-O19 with baseline hypermethylation of the DCC promoter were treated with 5-aza-2'-deoxycytidine (a demethylating agent) and reexpression of DCC was noted. Transfection of DCC into DCC-negative HNNSCC cell lines resulted in complete abrogation of growth in all cell lines, whereas additional cotransfection of netrin-1 resulted in rescue of DCC-mediated growth inhibition. These results suggest that DCC is a putative conditional tumor-suppressor gene that is epigenetically inactivated by promoter hypermethylation in a majority of HNSCC.